Xeris Biopharma Holdings Inc (NASDAQ:XERS) currently has a daily average trading volume of 2.25M but it saw 4679732 shares traded in last market. With a market cap of 855.23M USD, the company’s current market price of $5.34 came rising about 11.95 while comparing to the previous closing price of $4.77. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.07 and as low as $2.10. In the recent trading on the day, stock has struck highest price mark of $4.82 while lowest mark touched by it was $5.36.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Sandler which downgraded the stock as “Neutral” in its note to investors issued on November 11, 2024, recommending a price target of $3 for it. Craig Hallum issued its recommendations for the stock as it initiated the price target for the stock is $4.50.
Over the week, XERS’s stock price is moving 14.59% up while it is 16.59% when we observe its performance for the past one month. Year-to-date it is 153.08% up and over the past year, the stock is showing an upside performance of 57.52%.
Currently, Xeris Biopharma Holdings Inc’s total number of outstanding shares is 156.01M. Company’s return on investment (ROI) stands at -20.91%. It has a 43.06 of forward P/E ratio. Stock’s beta reads 0.69. Stock has a price to sale or P/S ratio amounts to 3.84. Its return on asset (ROA) is -13.83% on average.
